{"id":"W2612006186","doi":"10.2147/ott.s104177","title":"New developments in the treatment of advanced squamous cell lung cancer: focus on afatinib","year":2017,"lang":"en","type":"review","venue":"OncoTargets and Therapy","topic":"Lung Cancer Treatments and Mutations","field":"Medicine","cited_by":35,"is_retracted":false,"has_abstract":true,"ca_institutions":"Royal Victoria Hospital","funders":"","keywords":"Afatinib; Medicine; Nivolumab; Lung cancer; Pembrolizumab; Ramucirumab; Oncology; Docetaxel; Context (archaeology); Squamous-cell carcinoma of the lung; Internal medicine; Chemotherapy; Cancer; Intensive care medicine; Immunotherapy; Epidermal growth factor receptor; Erlotinib","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00005994695,0.0003663496,0.001175037,0.0001069271,0.0001156181,0.00002364983,0.0001264095,0.0001211163,0.00005301623],"category_scores_gemma":[0.000003960512,0.0001822114,0.0002150493,0.0000867042,0.00002834231,0.00003374887,0.000006804004,0.0001078649,0.000003441431],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0002866948,"about_ca_system_score_gemma":0.0008675091,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0007188202,"about_ca_topic_score_gemma":0.0001198623,"domain_scores_codex":[0.9988539,0.00005176706,0.0003664908,0.0003213062,0.00018914,0.0002174575],"domain_scores_gemma":[0.9990187,0.0001124487,0.0003457901,0.0004074235,0.00002788871,0.000087697],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.00007755814,0.0005547921,0.0004060599,0.0007144097,0.0002604243,0.00003388868,0.001453953,4.978373e-7,5.629773e-7,0.0000425628,0.0002630076,0.9961923],"study_design_scores_gemma":[0.004822685,0.001321047,0.000698233,0.002550934,0.0005654762,0.000006986198,0.0000312208,5.394031e-7,0.00001948514,0.00003086426,0.9897873,0.0001651685],"study_design_candidate":"design_other","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.0006498618,0.9890403,0.000001460703,0.000155832,0.0002222129,0.002112073,0.00006182765,0.000009681598,0.007746751],"genre_scores_gemma":[0.001659596,0.9945685,0.000331491,0.00006104127,0.0001511659,0.0004874981,0.00008222347,0.00003937717,0.002619077],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.9960271,"threshold_uncertainty_score":0.7430366,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.05241281530813648,"score_gpt":0.4199899764586437,"score_spread":0.3675771611505073,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}